CN101738474B - 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 - Google Patents
一种巨细胞病毒、风疹病毒联合检测试剂检测卡 Download PDFInfo
- Publication number
- CN101738474B CN101738474B CN 200910255653 CN200910255653A CN101738474B CN 101738474 B CN101738474 B CN 101738474B CN 200910255653 CN200910255653 CN 200910255653 CN 200910255653 A CN200910255653 A CN 200910255653A CN 101738474 B CN101738474 B CN 101738474B
- Authority
- CN
- China
- Prior art keywords
- solution
- cytomegalovirus
- rubella virus
- card
- test strips
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 78
- 241000701022 Cytomegalovirus Species 0.000 title claims abstract description 57
- 241000710799 Rubella virus Species 0.000 title claims abstract description 54
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 14
- 238000001514 detection method Methods 0.000 claims abstract description 52
- 239000000427 antigen Substances 0.000 claims abstract description 33
- 102000036639 antigens Human genes 0.000 claims abstract description 33
- 108091007433 antigens Proteins 0.000 claims abstract description 33
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 18
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 78
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 48
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 32
- 239000012895 dilution Substances 0.000 claims description 19
- 238000010790 dilution Methods 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 19
- 241001494479 Pecora Species 0.000 claims description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 16
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 16
- 229910052708 sodium Inorganic materials 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 16
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 15
- 239000011259 mixed solution Substances 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000009434 installation Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000013049 sediment Substances 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 8
- 241001062009 Indigofera Species 0.000 claims description 5
- SJUCACGNNJFHLB-UHFFFAOYSA-N O=C1N[ClH](=O)NC2=C1NC(=O)N2 Chemical compound O=C1N[ClH](=O)NC2=C1NC(=O)N2 SJUCACGNNJFHLB-UHFFFAOYSA-N 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 230000004888 barrier function Effects 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 230000001154 acute effect Effects 0.000 abstract description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract 2
- 241000283707 Capra Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000010931 gold Substances 0.000 abstract 1
- 229910052737 gold Inorganic materials 0.000 abstract 1
- 238000002965 ELISA Methods 0.000 description 10
- 230000008021 deposition Effects 0.000 description 7
- 238000012913 prioritisation Methods 0.000 description 7
- 201000005404 rubella Diseases 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 241000700605 Viruses Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229920002477 rna polymer Polymers 0.000 description 3
- 238000009666 routine test Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 102100021696 Syncytin-1 Human genes 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000001739 intranuclear inclusion body Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910255653 CN101738474B (zh) | 2009-12-16 | 2009-12-16 | 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910255653 CN101738474B (zh) | 2009-12-16 | 2009-12-16 | 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101738474A CN101738474A (zh) | 2010-06-16 |
CN101738474B true CN101738474B (zh) | 2013-02-27 |
Family
ID=42462214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910255653 Expired - Fee Related CN101738474B (zh) | 2009-12-16 | 2009-12-16 | 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101738474B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103235134B (zh) * | 2013-05-08 | 2015-10-14 | 成都创宜生物科技有限公司 | 一种检测胎膜早破的免疫层析试纸及其制备方法 |
CN103675271B (zh) * | 2013-12-23 | 2016-01-06 | 北京新华联协和药业有限责任公司 | 过敏性疾病变应原胶体金诊断试纸条及其制备方法 |
CN105785001A (zh) * | 2016-04-26 | 2016-07-20 | 中国科学院微生物研究所 | 一种检测猪巨细胞病毒胶体金试纸条 |
CN106442980A (zh) * | 2016-08-28 | 2017-02-22 | 张金凤 | 一种快速检测人流行性乙型脑炎病毒IgM抗体的试纸 |
CN109856408A (zh) * | 2019-04-09 | 2019-06-07 | 潍坊市康华生物技术有限公司 | 一种柯萨奇病毒A6型和A10型IgM抗体联合检测试剂盒及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1414389A (zh) * | 2002-08-19 | 2003-04-30 | 上海华冠生物芯片有限公司 | Hcv和torch蛋白芯片及其制备和应用方法 |
US20040235189A1 (en) * | 2003-05-08 | 2004-11-25 | Lu Wei Zhao | Reversed chromatographic immunoassay |
CN101158684A (zh) * | 2007-11-06 | 2008-04-09 | 山东省医药生物技术研究中心 | 同时检测ToRCH感染的免疫层析试纸及制备方法 |
CN101221177A (zh) * | 2008-01-25 | 2008-07-16 | 马义才 | 一种便携式胎儿致畸疾病快速联检装置 |
CN101421621A (zh) * | 2004-02-17 | 2009-04-29 | 比南股份有限公司 | 检测多种病原体的方法和试剂盒 |
CN101573617A (zh) * | 2006-08-03 | 2009-11-04 | 瑞必诊有限公司 | 免疫试验中的免疫层析试条和包括该试条的试剂盒 |
-
2009
- 2009-12-16 CN CN 200910255653 patent/CN101738474B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1414389A (zh) * | 2002-08-19 | 2003-04-30 | 上海华冠生物芯片有限公司 | Hcv和torch蛋白芯片及其制备和应用方法 |
US20040235189A1 (en) * | 2003-05-08 | 2004-11-25 | Lu Wei Zhao | Reversed chromatographic immunoassay |
CN101421621A (zh) * | 2004-02-17 | 2009-04-29 | 比南股份有限公司 | 检测多种病原体的方法和试剂盒 |
CN101573617A (zh) * | 2006-08-03 | 2009-11-04 | 瑞必诊有限公司 | 免疫试验中的免疫层析试条和包括该试条的试剂盒 |
CN101158684A (zh) * | 2007-11-06 | 2008-04-09 | 山东省医药生物技术研究中心 | 同时检测ToRCH感染的免疫层析试纸及制备方法 |
CN101221177A (zh) * | 2008-01-25 | 2008-07-16 | 马义才 | 一种便携式胎儿致畸疾病快速联检装置 |
Also Published As
Publication number | Publication date |
---|---|
CN101738474A (zh) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Serological diagnosis of toxoplasmosis and standardization | |
CN101587043B (zh) | 从生物体液样本中富集与检测稀有细胞的整合方法 | |
CN101738474B (zh) | 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 | |
LEWIS et al. | Hemagglutination in the diagnosis of toxoplasmosis and amebiasis | |
CN105223361B (zh) | 一种检测急性t淋巴细胞白血病幼稚t细胞的试剂盒、应用及方法 | |
CN101819206A (zh) | 产前筛查afp测定试剂盒(时间分辨荧光免疫法)及其制备方法 | |
CN106226518A (zh) | 犬瘟热病毒胶体金免疫层析检测试纸条及其制备方法 | |
CN103698511A (zh) | 结核分支杆菌蛋白在制备诊断潜伏性肺结核感染的产品中的用途 | |
CN203083997U (zh) | ABO、RhD血型抗原检测卡 | |
Bell et al. | Multicenter clinical performance evaluation of BD Veritor™ system for rapid detection of respiratory syncytial virus | |
CN105181964B (zh) | 水貂阿留申病毒抗体胶体金检测试纸条及其制备方法 | |
Lei et al. | Different methods of COVID-19 detection | |
CN104990905B (zh) | 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒 | |
CN103149357B (zh) | 一种利用竞争法检测牛布鲁氏菌抗体的检测试纸卡 | |
CN102368068B (zh) | 检测肺炎衣原体IgM抗体的试剂盒 | |
CN103698531B (zh) | Rv1860、Rv0173和/或Rv1812c蛋白在制备诊断活动性肺结核的产品中的用途 | |
CN109085355A (zh) | 血清蛋白标志物组合在肺癌筛查和诊治中的应用 | |
CN103149356B (zh) | 一种利用夹心法检测牛布鲁氏菌抗原的检测试纸卡 | |
CN103675293B (zh) | Rv3872、Rv0164和/或Rv1926c蛋白在制备诊断活动性肺结核的产品中的用途 | |
Reichart et al. | Evaluation of Abbott Testpack® Chlamydia for detection of Chlamydia trachomatis in patients attending sexually transmitted diseases clinics | |
CN102095860B (zh) | 梅毒特异性IgG抗体免疫印迹试剂盒及其制备方法 | |
CN201926662U (zh) | 梅毒特异性总抗体免疫印迹试剂盒 | |
CN108318681A (zh) | 一种库波热病毒的检测试剂盒及其检测方法 | |
Carter et al. | Assessment of an antibody-in-lymphocyte supernatant assay for the etiological diagnosis of pneumococcal pneumonia in children | |
CN103675292B (zh) | Rv0174、Rv1729c和/或Rv3835蛋白在制备诊断活动性肺结核的产品中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEIFANG KANGHUA BIOTECH. CO., LTD. Free format text: FORMER OWNER: YANG ZHITING Effective date: 20130521 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 261041 WEIFANG, SHANDONG PROVINCE TO: 261003 WEIFANG, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130521 Address after: 261003 Shandong city of Weifang Province River Road Economic Development Zone No. 699 Patentee after: WEIFANG KANGHUA BIOTECH Co.,Ltd. Address before: 261041 Shandong city of Weifang Province River Road Economic Development Zone No. 699 Patentee before: Yang Zhiting |
|
CP03 | Change of name, title or address |
Address after: 261023 Shandong city of Weifang Province River Road Economic Development Zone No. 699 Patentee after: Shandong Kanghua Biomedical Technology Co.,Ltd. Address before: 261003 Shandong city of Weifang Province River Road Economic Development Zone No. 699 Patentee before: WEIFANG KANGHUA BIOTECH Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130227 |